| abstract |
The use of phospholipids of formula (I) to reduce inflammation and the viscosity of mucus in a patient is described, wherein one of X, Y, or Z represents: (a) in which each R represents hydrogen or methyl, and each of the other two of X, Y, or Z represents -CO-R1 in which R1 represents linear or branched C¿11-21? alkyl or C11-21 alkenyl, unsubstituted or substituted with one or more substituents selected from the group consisting of halo, C1-6 linear or branched alkoxy or cyano. |